SLC43A2 and neoplasm: Methionine/cystine restriction (MCR) and inhibition of SLC43A2, a methionine transporter, suppress tumor progression of esophageal squamous cell carcinoma by diminishing phosphorylation of IKKα/β and p65 [88].